SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4676 121 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3801apparently folks are seeing the alny deal as positive for isis today as i got thbob zagorin-9/8/2005
3800S-3 filing for shares sold back in august... xml.10kwizard.combob zagorin-9/7/2005
3799[Inhibition of STAT3 versus prostate cancer] >>Clinical Cancer Research Vtuck-9/7/2005
3798from yahoo board... i think this is accurate.. "...According to the ALNY 1bob zagorin-9/7/2005
3797isis has a partnership with ALNY which today announced major $700m deal with novbob zagorin-9/7/2005
3796OncoGenex Phase I Study of OGX-011 in Prostate Cancer Meets Primary and Secondarmanny t-9/7/2005
3795Isis's new partner, iCo, was apparently formed very recently. From what I cExtra Pale-8/26/2005
3794here's the full text.... Isis Pharmaceuticals Licenses Antisense Drug to iCbob zagorin-8/25/2005
3793Full release is at biz.yahoo.com VANCOUVER, British Columbia and CARLSBAD, Calitom pope-8/25/2005
3792from zacks... can you believe it predicting profits of $2.36/share in two years.bob zagorin-8/24/2005
3791Here is an excerpt from the April, 2005, article "In the Business of SyntheDavid Bogdanoff-8/24/2005
3790OT but interesting. Wednesday, August 24, 2005 - 12:00 AM Wall Street biotech bob zagorin-8/24/2005
3789<Why would the company do a private placement instead of an offer to the geneExtra Pale-8/23/2005
3788Here is a thought: there are fees and expenses for offerings to the general publDavid Bogdanoff-8/23/2005
3787I read recently on another thread that there is a Peter rule that if a secondartom pope-8/23/2005
3786Why would the company do a private placement instead of an offer to the general markjbloggs-8/23/2005
3785<Warrants, too. Ouch. I expect this to be a firesale tomorrow. Down 13% afterExtra Pale-8/23/2005
3784>>CARLSBAD, Calif., Aug. 22 /PRNewswire-FirstCall/ -- Isis Pharmaceuticalstuck-8/23/2005
3783I agree with your strategy to a point. The thing is that hordes of analysts canDavid Bogdanoff-8/20/2005
3782i watch him when i can and don't want to be too negative because he's rebob zagorin-8/20/2005
3781I generally agree with your assessment of Cramer. I would add that he can "David Bogdanoff-8/19/2005
3780truly, if somneone has invested in isis on the hope that cramer might give them bob zagorin-8/18/2005
3779Cramers anti-recommendation is the kiss of death to ISIS's stock price tomorDavid Bogdanoff-8/17/2005
3778FWIW>> Cramer gave ISIS the BEAR signal on Mad Money. His comment: "LJM-8/17/2005
3777OncoGenex Announces Completion of $12.8 Million Venture Financing Tuesday Augustbob zagorin-8/16/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News